Constantí Serrallonga
Direktor/Vorstandsmitglied bei Archivel Farma SL
Aktive Positionen von Constantí Serrallonga
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Archivel Farma SL
 Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Direktor/Vorstandsmitglied | 07.09.2011 | - |
Karriereverlauf von Constantí Serrallonga
Ausbildung von Constantí Serrallonga
| University of Barcelona | Undergraduate Degree |
Statistik
International
| Spanien | 3 |
Operativ
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Commercial Services |
- Börse
- Insiders
- Constantí Serrallonga
- Erfahrung
